When Zofran (ondansetron) first went on the market in the early 1990s, it was widely embraced as a new way to relieve nausea and vomiting for cancer patients undergoing chemotherapy and radiation treatments.
It wasn’t long before the drug found another major market: expectant mothers seeking relief from morning sickness. The United States Food and Drug Administration (FDA) never approved Zofran for that purpose, but according to consumer protection groups, drugmaker GlaxoSmithKline aggressively marketed Zofran “off-label” to pregnant women, without the green light from the FDA.
Sadly, Zofran (and its generic versions) used during pregnancy has been linked to a wide range of birth defects.
Working in collaboration with other national law firms, Berman & Simmons is handling claims involving people who took Zofran and whose unborn children suffered injuries or birth defects. There are strict statutes of limitations in dangerous drug cases, so it’s important to get in touch with us as soon as possible if you believe you have a potential Maine Zofran lawsuit.